Dashboard
Manage Tickers

AKRO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

this-keysight-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-friday
This Keysight Analyst Is No Longer Bullish...
10/10/2025 13:53:02

wolfe-research-downgrades-akero-therapeutics-to-peer-perform
Wolfe Research Downgrades Akero Therapeuti...
10/10/2025 11:27:50

Wolfe Research analyst Andy Chen downgrades Akero Therapeutics (NASDAQ:AKRO) from Outperform to Peer Perform.

hc-wainwright--co-downgrades-akero-therapeutics-to-neutral-lowers-price-target-to-54
HC Wainwright & Co. Downgrades Akero Thera...
10/10/2025 10:56:38

HC Wainwright & Co. analyst Andrew S. Fein downgrades Akero Therapeutics (NASDAQ:AKRO) from Buy to Neutral and lowers th...

akero-therapeutics-says-if-deal-terminated-under-some-circumstances-co-to-pay-165m-termination-fee-to-novo-nordisk
Akero Therapeutics Says If Deal Terminated...
10/09/2025 20:50:12

-SEC Filing

jefferies-downgrades-akero-therapeutics-to-hold-lowers-price-target-to-56
Jefferies Downgrades Akero Therapeutics to...
10/09/2025 16:15:35

Jefferies analyst Andrew Tsai downgrades Akero Therapeutics (NASDAQ:AKRO) from Buy to Hold and lowers the price target from ...

canaccord-genuity-downgrades-akero-therapeutics-to-hold-lowers-price-target-to-54
Canaccord Genuity Downgrades Akero Therape...
10/09/2025 15:38:55

Canaccord Genuity analyst Edward Nash downgrades Akero Therapeutics (NASDAQ:AKRO) from Buy to Hold and lowers the price targ...

tilray-brands-posts-upbeat-results-joins-byrna-technologies-delta-air-lines-and-other-big-stocks-moving-higher-on-thursday
Tilray Brands Posts Upbeat Results, Joins ...
10/09/2025 14:14:52

novo-nordisk-to-acquire-liver-disease-focused-akero-therapeutics-for-around-5-billion
Novo Nordisk To Acquire Liver Disease Focu...
10/09/2025 13:10:21

Novo Nordisk to buy Akero Therapeutics for up to $5.2 billion, adding EFX, a late-stage MASH treatment candidate, to its metabo...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/09/2025 12:07:59

Core News & Articles
Novo Nordisk To Acquire Akero Therapeutics...
10/09/2025 10:03:27

akero-therapeutics-to-present-96-week-phase-2b-symmetry-and-harmony-data-on-efruxifermin-at-76th-aasld-the-liver-meeting-2025
Akero Therapeutics To Present 96-Week Phas...
10/07/2025 11:10:09

hc-wainwright--co-assumes-akero-therapeutics-at-buy-announces-price-target-of-72
HC Wainwright & Co. Assumes Akero Therapeu...
09/04/2025 11:14:25

HC Wainwright & Co. analyst Andrew S. Fein assumes Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and announces Pric...

akero-publishes-96-week-phase-2b-harmony-trial-results-in-the-lancet-showing-near-complete-mash-reversal-in-one-third-of-patients-on-50mg-efx
Akero Publishes 96-Week Phase 2b HARMONY T...
08/14/2025 22:31:16

Akero Therapeutics, Inc. (NASDAQ:AKRO), a clinical-stage company developing transformational treatments for patients with serio...

akero-therapeutics-q2-eps-086-beats-093-estimate
Akero Therapeutics Q2 EPS $(0.86) Beats $(...
08/08/2025 11:18:02

Akero Therapeutics (NASDAQ:AKRO) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(...

this-aerovironment-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This AeroVironment Analyst Begins Coverage...
08/04/2025 15:30:00

td-cowen-initiates-coverage-on-akero-therapeutics-with-buy-rating-announces-price-target-of-76
TD Cowen Initiates Coverage On Akero Thera...
08/04/2025 11:38:45

TD Cowen analyst Ritu Baral initiates coverage on Akero Therapeutics (NASDAQ:AKRO) with a Buy rating and announces Price Tar...

b-of-a-securities-maintains-buy-on-akero-therapeutics-raises-price-target-to-64
B of A Securities Maintains Buy on Akero T...
05/27/2025 15:20:22

B of A Securities analyst Alexandria Hammond maintains Akero Therapeutics (NASDAQ:AKRO) with a Buy and raises the price targ...

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
05/20/2025 17:35:25

watching-akero-therapeutics-shares-spike-higher-traders-circulate-unconfirmed-rumor-of-potential-sale
Watching Akero Therapeutics; Shares Spike ...
05/20/2025 17:29:40

citigroup-maintains-buy-on-akero-therapeutics-lowers-price-target-to-78
Citigroup Maintains Buy on Akero Therapeut...
05/13/2025 19:16:38

Citigroup analyst Jonathan Woo maintains Akero Therapeutics (NASDAQ:AKRO) with a Buy and lowers the price target from $80 to...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION